Quality evaluation for the surveillance system of human prion diseases in China based on the data from 2010 to 2016.
The surveillance of CJD or human prion diseases (PrDs) has been conducted for 10 y in China. To evaluate the quality of China CJD surveillance system, the collections of the clinical and epidemiological information, the sampling, the clinical examinations and laboratory tests and follow-up survey were separately analyzed based on the data from 2010 to 2015. The obtaining rates of clinical-information table, epidemiological-information table, sample inspection sheet and medical record of the referring patients from reporting units to the center of CJD surveillance maintained or reached at very high levels, being close to 100% in the past 3 y. 93.82%, 85.23%, 96.21% and 94.70% of the reported cases had the data of MRI, EEG, CSF 14-3-3 and PRNP sequencing, respectively. Follow-up surveys were conducted in about 50% cases in 2010 and 2011, 93.39% cases in 2012 and 100% cases in the last 3 y. High obtaining rates of the clinical and epidemiological data, high conducting rates of the relevant clinical examinations and laboratory tests, high performing rates of follow-up survey for every referring case reflect a good implemental capacity in China CJD surveillance system, which supplies solid basis for recognition and diagnosis of human prion diseases and guarantees good quality of China CJD surveillance system.
a State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University, Hangzhou), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention , Beijing , People's Republic of China.
Qi
Q
Shi
a State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University, Hangzhou), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention , Beijing , People's Republic of China.
Wei
W
Zhou
a State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University, Hangzhou), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention , Beijing , People's Republic of China.
Cao
C
Chen
a State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University, Hangzhou), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention , Beijing , People's Republic of China.
Chen
C
Gao
a State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University, Hangzhou), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention , Beijing , People's Republic of China.
Kang
K
Xiao
a State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University, Hangzhou), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention , Beijing , People's Republic of China.
Jing
J
Wang
a State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University, Hangzhou), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention , Beijing , People's Republic of China.
Bao-Yun
BY
Zhang
a State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University, Hangzhou), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention , Beijing , People's Republic of China.
Yuan
Y
Wang
a State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University, Hangzhou), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention , Beijing , People's Republic of China.
Feng
F
Zhang
a State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University, Hangzhou), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention , Beijing , People's Republic of China.|b Chinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences , Beijing , People's Republic of China.
Xiao-Ping
XP
Dong
D002681:China / Q000453:epidemiology; D004569:Electroencephalography; D049674:History, 21st Century; D006801:Humans; D008279:Magnetic Resonance Imaging; D011159:Population Surveillance; D017096:Prion Diseases / Q000134:cerebrospinal fluid / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000503:physiopathology; D000072002:Prion Proteins / Q000235:genetics; D011786:Quality Control
C512656:PRNP protein, human; D000072002:Prion Proteins
Creutzfeldt-Jakob disease; evaluation; human prion diseases; quality; surveillance
Infect Dis Poverty. 2016 Jun 02;5(1):47
27251305
BMC Neurol. 2015 Dec 02;15:250
26630984
Brain Pathol. 1995 Oct;5(4):459-66
8974629
Brain Pathol. 1998 Jul;8(3):499-513
9669700
Swiss Med Wkly. 2015 Nov 12;145:w14212
26715203
Prion. 2015;9(4):304-14
26251963
PLoS One. 2015 Oct 21;10 (10 ):e0139552
26488179
J Clin Epidemiol. 2000 Jul;53(7):747-54
10941953
Nat Rev Neurol. 2011 Sep 05;7(9):479-80
21892213
MMWR Morb Mortal Wkly Rep. 1996 Aug 9;45(31):665-8
8769655
APMIS. 2002 Jan;110(1):88-98
12064260
Lancet Neurol. 2012 Jul;11(7):618-28
22710755
BMC Public Health. 2008 Oct 18;8:360
18928564
Brain. 2007 May;130(Pt 5):1350-9
17472986
Eur J Epidemiol. 2010 May;25(5):341-7
20333444
Nat Rev Neurol. 2012 Apr 10;8(5):241
22487751
BMJ. 1997 Aug 16;315 (7105):389-95
9277601
Can Commun Dis Rep. 1999 Jan 1;25(1):7-8
9926624
Prion. 2015;9(2):136-43
25996401
PLoS One. 2011;6(8):e24231
21904617